GFAP and dementia: Plasma GFAP at baseline had a high accuracy for separating patients with stable MCI and MCI to dementia conversion (AUC = 0.90) after an average follow-up of 4.1 ± 2.3 years, with a sensitivity of 90% and specificity of 81% at an optimal cut-off of 100.2 pg/mL.